TB-500 Peptide (TB4)

For Research Use Only. Not for human use.

TB-500 (Thymosin Beta-4 Fragment) is a synthetic research peptide frequently studied in preclinical studies on cellular migration, tissue repair pathways, angiogenesis, and cytoskeletal organization. As a key actin-binding peptide fragment, TB-500 is widely used across regenerative biology, musculoskeletal studies, and wound-healing research models. According to published scientific literature, TB-500 functions as a major G-actin sequestering molecule, regulating actin polymerization processes central to cellular migration and structural reorganization .

Our TB-500 peptide is manufactured under strict analytical standards and supplied as a stable lyophilized powder to ensure experimental consistency, purity, and long-term reliability.

Key Scientific Features

• High-purity, research-grade TB-500 peptide
• Lyophilized formulation for enhanced stability during storage
• Full Certificate of Analysis (COA) verifying purity and identity
• Stringent quality-controlled manufacturing environment
• Optimized for regenerative, cellular, and musculoskeletal research applications

Research-Referenced Applications (Based on existing scientific literature; not intended as therapeutic claims.) TB-500 is commonly explored in preclinical models involving:

• Cellular migration & cytoskeletal reorganization pathways
• Muscle, tendon, and ligament tissue research models
• Regenerative-tissue and wound-healing studies
• Angiogenesis and microvascular remodeling
• Inflammatory and oxidative-stress response signaling
• Actin-regulation and cell-mobility mechanisms

Why Researchers Choose Nationwide Peptides

• Pharmaceutical-grade synthesis protocols
• Analytical validation for purity, identity, and structural integrity
• Reproducible batch-to-batch consistency
• Transparent documentation and traceability
• Competitive research-market pricing
• Ideal for academic labs, biotechnology research groups, and peptide-science environments requiring high-stability, high-performance TB-500 peptide.